Revolutionizing Rodent Research: Gel-Based Oral Drug Delivery for Precision Dosing

Introduction

In biomedical research, accurate drug dosing in animal models is essential for reliable results. However, traditional methods like drug-infused chow, oral gavage, or injections come with challenges—uncontrolled dosing, stress, or risk of injury to animals. A recent breakthrough study introduces a gel-based oral drug delivery system that offers a precise, minimally invasive alternative for small molecule administration in mice.

The Problem with Traditional Methods

Small molecules such as PLX5622 (for microglia depletion) and tamoxifen (for inducible Cre recombination) are widely used in neuroscience and genetics research. Conventional delivery methods have significant drawbacks:

Drug-infused chow: Unpredictable consumption leads to variable dosing.
Oral gavage or injections: Cause stress and risk of physical harm to the animals.

Researchers needed a solution that balanced precise dosing, reproducibility, and animal welfare.

The Gel-Based Solution

The study developed an innovative system using DietGel 93M, a complete maintenance gel diet, infused with small molecules for oral delivery. Key features include:

Precise dose control: Researchers can adjust drug concentrations easily.
Minimally invasive: No need for stressful handling like injections.
High efficacy: Achieved >99% microglia depletion and efficient Cre recombination in mice.

Key Findings

Controlled Microglia Depletion: Both low (0.8 mg/g) and high (2.0 mg/g) doses of PLX5622 achieved >99% depletion after two weeks.
Efficient Gene Recombination: Tamoxifen-infused gel induced robust Cre-dependent gene activation in retinal Müller glia.
Animal Welfare Benefits: Reduced stress, no need for invasive procedures, and minimal body weight fluctuations in mice.

Applications Beyond the Retina

While the study focused on retinal research, this gel-based delivery system could be adapted for other tissues, drugs, and experimental models, making it a versatile tool for biomedical studies.

Conclusion

This breakthrough demonstrates how gel-based oral drug delivery can revolutionize animal research, ensuring precise dosing, reproducibility, and better animal welfare. Future studies may expand this method to other therapeutic agents and research areas, opening doors to more accurate and humane experimentation.

Reference

Jovanovic, J., Stone, M. L., Dooyema, S. R., Tao, Y. K., Fuhrmann, S., & Levine, E. M. (2025). Diet gel-based oral drug delivery system for controlled dosing of small molecules for microglia depletion and inducible Cre recombination in mice. Lab Animal. https://doi.org/10.1038/s41684-025-01617-1